FDA approves bevacizumab-bvzr for several cancersJune 28, 2019Gynecologic CancerRenal Cell CarcinomaLung CancerGastroenterologyGenitourinary CancerCNS/Brain CancerNeuro-oncology
EHR default order slashes unnecessary imaging during palliative RTJune 28, 2019Practice ManagementCNS/Brain CancerSarcoma & GIST
Trial matches pediatric cancer patients to targeted therapiesMay 31, 2019Sarcoma & GISTPediatricsRenal Cell CarcinomaCNS/Brain CancerGenitourinary Cancer
Entrectinib exhibits activity in children with solid tumorsMay 23, 2019CNS/Brain CancerPediatricsMelanomaSarcoma & GIST
Liquid biopsy falls short for isolated brain lesions in lung cancerApril 16, 2019Lung CancerCNS/Brain CancerNeuro-oncology
Combo shows promise in HER2-positive breast cancer with brain metsMarch 15, 2019Breast CancerCNS/Brain Cancer
FDA Expanded Access benefits heavily pretreated patients, especially childrenMarch 4, 2019Practice ManagementCNS/Brain CancerBreast CancerLung Cancer
Ibrutinib-MTX-rituximab combo shows promise in CNS lymphomaFebruary 11, 2019Lymphoma & Plasma Cell DisordersCNS/Brain Cancer
Proposed neuroblastoma classification scheme hinges on telomere maintenance mechanismsDecember 6, 2018CNS/Brain CancerNeuro-oncology
Stereotactic radiotherapy highly effective for brain mets in RCCNovember 30, 2018Renal Cell CarcinomaGenitourinary CancerCNS/Brain Cancer
SRS beats surgery in early control of brain mets, advantage fades with timeNovember 9, 2018CNS/Brain CancerBreast CancerMelanomaGastroenterologyGenitourinary CancerRenal Cell CarcinomaGastrointestinal Cancer
